荧光团
免疫分析
材料科学
等离子体子
探测器
荧光
纳米技术
多路复用
微阵列
灵敏度(控制系统)
生物标志物
检出限
仪表(计算机编程)
生物医学工程
计算机科学
光电子学
DNA微阵列
作者
Daria Semeniak,Deniz Acil,Jason Liu,Daniela Cruz,Cassio Mendes Fontes,Chengyang Li,Brooke E. Silverstein,Gary Michael Felker,Angus Hucknall,Maiken H. Mikkelsen,Ashutosh Chilkoti
摘要
Point‑of‑care testing (POCT) demands diagnostic platforms that pair high analytical sensitivity with compact, low‑cost readout hardware, yet fluorescence‑based immunoassays face a fundamental tradeoff between detector cost and detection performance. Plasmonic nanocavities-such as metal-dielectric-metal nanopatch antennas-offer a powerful signal‑amplification strategy by dramatically enhancing fluorophore emission, enabling sensitive fluorescence detection with inexpensive optics. Here, we introduce a plasmonically enhanced fluorescence microarray immunoassay that integrates nanopatch antennas for high‑sensitivity, low‑cost quantification of key heart‑failure biomarkers, NT‑proBNP, NGAL, and galectin‑3, using a custom smartphone‑based detector. The nanopatch antennas yield up to 485‑fold fluorescence enhancement enabling quantitative and multiplexed detection with limits of detection of 0.055, 3.932, and 0.864 ng/mL, respectively. Analysis of NT‑proBNP-positive human samples shows strong correlation with clinically validated assays, demonstrating the potential of this plasmonically enhanced platform to deliver high‑performance heart‑failure biomarker monitoring at low cost in resource‑limited and point‑of‑care settings.
科研通智能强力驱动
Strongly Powered by AbleSci AI